A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body
Clinical trial NCT03173625 · COMPLETED
Trial details
- NCT number
- NCT03173625
- Sponsor
- Viatris Innovation GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2017-04-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.